Fundraising Fox

Antony Loebel

Executive at Seaport Therapeutics

New York City Metropolitan Area

Find your path to Antony

38 people in our graph share verified history with Antony — schools, employers, funds. One of them is your warm intro.

Steve PaulunlockedAntony: together at Seaport Therapeutics (2024–2026)
Antony: together at Sunovion Pharmaceuticals
×6Antony: together at University of Washington - School of Medicine
×2Antony: together at Seaport Therapeutics

Executive at Seaport Therapeutics

Intro paths

→

In turn, Antony can intro founders to Seaport Therapeutics's investors below.

Seaport Therapeutics's investors · 6

ARCH Venture PartnersChicago · $50K – $250M checks · since 2024Foresite CapitalWest Hollywood · since 2024HAWKTAILSan Francisco · since 2024PureTech HealthBoston · since 2024Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2024Third Rock VenturesBoston · $100K – $5M checks

Co-founders at Seaport Therapeutics

DZDaphne Zohar
Daphne ZoharFounder, CEO and Board Member

Experience

  1. Seaport TherapeuticsCMO & President Clinical Developmentcurrent2024 — presentBoston, Mass
  2. Sunovion PharmaceuticalsPresident and Chief Executive Officer2019 — 2023
  3. Sunovion PharmaceuticalsExecutive Vice President, Chief Medical Officer and Head of Global Clinical Development2011 — 2019Marlborough, MA & Ft Lee, NJ
  4. Sunovion Pharmaceuticals Inc.Chief Medical Officer; Head, Global Clinical Development (GCD)2011 — 2019Marlborough, MA and Fort Lee, NJ
  5. Sunovion Pharmaceuticals Inc.Senior Vice President and Head, Clinical Development & Medical Affairs2010 — 2011
  6. Dainippon Sumitomo Pharma AmericaVice President, Clinical Development2007 — 2010
  7. PfizerMedical Director/Senior Medical Director2001 — 2007

Skills & more

Organizational CultureOrganizational Change ManagementPharmaceutical IndustryBiopharmaceuticalsCorporate LeadershipExecutive LeadershipExecutive VisibilityClinical DevelopmentGlobal Drug DevelopmentClinical TrialsClinical ResearchMedical Affairs
+12 moreCommercial LeadershipStrategic PartnershipsBusiness StrategyMission CriticalRegulatory SubmissionsInvestor PresentationsMedical CommunicationsPsychiatryNeurologyNeuroscienceDrug DevelopmentCommercialization
  • Board-certified psychiatrist — American Board of Psychiatry and Neurology, Inc.

From Antony's professional profile.

Frequently asked questions

Who is Antony Loebel?
Executive Officer at Seaport Therapeutics
Where does Antony Loebel work?
Antony Loebel is Executive at Seaport Therapeutics.
Where did Antony Loebel go to school?
Antony Loebel studied at University of Washington - School of Medicine (Doctor of Medicine (MD)); University of Washington (Bachelor of Arts (BA)).

Same school

Also attended University of Washington - School of Medicine20

Uri LopatinInvestor at Khosla VenturesDennis SchmulandInvestor at EPIC VENTURESDoug RossInvestor at DigitalDx VenturesDavid CohnInterim Chief Executive Officer and Chief Medical Officer at Oncology VenturesChing-Ping LinPartner & COO at Orbit StartupsJulien PhamFounder & Managing Partner at 3CC | Third Culture Capital

+ 14 more

Also attended University of Washington516

Andrew ChenGeneral Partner at Andreessen HorowitzArvind JainFounder & CEO of GleanJane MooneyCo-founder & VP, Strategy and Finance at Collaborative RoboticsVictoria TreygerGeneral Partner at Felicis VenturesAndrewAdvisor at Clear VenturesJoe HorsmanInvestor at Madrona Venture Group

+ 510 more

Shared employers

Also worked at Seaport Therapeutics5

Steve PaulVenture Partner at Third Rock Ventures; physician-scientist in neuroscience and CNS drug discoveryDaphne ZoharFounder, CEO and Board Member at Seaport TherapeuticsMichael ChenExecutive Officer at Seaport TherapeuticsLana GladsteinExecutive Officer at Seaport TherapeuticsEric GreenExecutive Officer at Seaport Therapeutics

Also worked at Sunovion Pharmaceuticals10

Kaitlyn LagascaManager, Talent Acquisition at Anzu PartnersDario DollerCo-founder at Modulate BioFred GrossmanExecutive Officer at Coya TherapeuticsCurtis LockshinExecutive Officer at Xenetic BiosciencesTim HealeyChief Commercial Officer at Tenax TherapeuticsTodd BazemoreExecutive Officer at KALA BIO

+ 4 more

Also worked at Dainippon Sumitomo Pharma America5

Yoshiharu UrunoInvestor at JIC Venture Growth InvestmentsTsuzuku TakumaInvestor at JIC Venture Growth InvestmentsTakuma TsuzukuCapitalist at JIC Venture Growth InvestmentsDavid BearssExecutive Officer, Director at Halia TherapeuticsF. Ty EdmondsonChief Legal Officer at Zai Lab

Also worked at Pfizer288

Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital

+ 282 more